CSPCHA115

N/A

Report date: 2025/11/06 15:39:30
NME

Base Information

Drug NameCSPCHA115
Drug Alias NameCT-133CSPCHA-115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor antagonists
TargetsProstaglandin D2 receptor
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co LtdBeijing Centaurus Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShouyao Holding (Beijing) Co Ltd
Inactive CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co LtdBeijing Centaurus Biopharma Co Ltd
Active IndicationsRhinitis, AllergicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A